Northern Sweden Health and Disease Study
Launched by UMEÅ UNIVERSITY · Feb 7, 2018
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The Northern Sweden Health and Disease Study (NSHDS) is a research project that aims to understand various health conditions, including heart disease, cancer, brain diseases, lung diseases, and infections. This study collects blood samples and survey information from people living in Northern Sweden to help researchers find out more about these diseases and their causes. It includes three main groups of participants: those in a health intervention program, women undergoing mammography screening, and individuals monitored for cardiovascular health.
If you live in Northern Sweden, you might be eligible to participate in this study—there are no specific age or gender requirements, and everyone in the community is welcome to join. Participants will provide blood samples and answer questions about their health, which will help scientists gather important data. This research could lead to better understanding and prevention of these serious health issues, benefiting everyone in the long run.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Residents in Northern Sweden
- Exclusion Criteria:
- • None
About Umeå University
Umeå University, a leading research institution in Sweden, is dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge technology and expert knowledge across various fields to address critical health challenges. Its commitment to ethical standards and patient safety ensures that all clinical trials conducted under its auspices are designed to generate robust scientific evidence, ultimately contributing to improved health outcomes and informed medical practices. Umeå University strives to foster a dynamic research environment that supports the development of new therapies and enhances the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Umeå, , Sweden
Umeå, Västerbotten, Sweden
Patients applied
Trial Officials
Göran Hallmans, MD PhD
Principal Investigator
Umeå University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials